drugset / Trial / NCT01259141
The Optimization of Mycoplasm Pneumonia Antibiotic Therapy
RandomizedParallel-groupOpen-labelTreatment
Summary
Mycoplasma pneumoniae, an important pathogen of community acquired pneumonia,are becoming more and more resistant to macrolide. The study aim is to optimize anti-infection therapy.
Timeline
- Start
- 2010-10
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | 0.5 unknown | — |
| Subject | Cefuroxime | Small molecule | 1.5 unknown | — |
| Subject | Moxifloxacin | Small molecule | 0.4 unknown | — |